Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| K2024-187-01 | Other Identifier | The First Affiliated Hospital of Chongqing Medical University |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Bladder cancer (BLCA), with its diverse histopathological features and varying patient outcomes, poses significant challenges in diagnosis and prognosis. Postoperative survival stratification based on radiomics feature and whole slide image feature may be useful for treatment decisions to improve prognosis. In this research, we aim to develop a deep learning-based prognostic-stratification system for automatic prediction of overall and cancer-specific survival in patients with BLCA.
Bladder cancer can be difficult to diagnose and predict outcomes for, as the disease can vary greatly between patients. This research aims to develop a new system that uses artificial intelligence to analyze patient information, including images from surgery and scans. This system could then automatically predict a patient's overall survival and how likely they are to survive specifically from bladder cancer. This information could be used by doctors to make better treatment decisions for each patient.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| BLCA | patients with bladder cancer who had surgery like radical cystectomy or transurethral resection of bladder tumour (TURBT). |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Deep learning system for prognostication prediction in bladder cancer | Other | develop and validate a deep learning system for prognostication prediction in bladder cancer based on CT radiomics and whole slide images. |
| Measure | Description | Time Frame |
|---|---|---|
| Overall survival | the time from the date of surgery to death from any cause or the date of last contact (censored observation) at the date of data cut-off. | up to 10 years |
| Measure | Description | Time Frame |
|---|---|---|
| Recurrence free survival | the time from the date of surgery to the date of first documented disease recurrence. Patients without recurrence at the time of analysis will be censored | up to 10 years |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
We included patients who had surgery only or who had neoadjuvant chemotherapy before surgery. We excluded patients with a postoperative diagnosis of non-urothelial carcinoma.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| QuanHao He | Contact | 800-555-5555 | 2020120460@stu.cqmu.edu.cn | |
| Mingzhao Xiao, PHD | Contact | 800-555-5555 | 2023140134@stu.cqmu.edu.cn |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Department of Urology, The First Affiliated Hospital of Chongqing Medical University | Recruiting | Chongqing | Chongqing Municipality | 400016 | China |
The datasets analyzed during the current study are not publicly available due to the privacy of patients but are available from the corresponding author on reasonable request.
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D001749 | Urinary Bladder Neoplasms |
| ID | Term |
|---|---|
| D014571 | Urologic Neoplasms |
| D014565 | Urogenital Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
Not provided
Not provided
Not provided
Not provided
Not provided
| D052776 |
| Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D001745 | Urinary Bladder Diseases |
| D014570 | Urologic Diseases |
| D052801 | Male Urogenital Diseases |